- Global Pharma News & Resources

Worldwide Organoids Industry to 2026 - by Organ, Application, End-user and Geography -

DUBLIN--(BUSINESS WIRE)--The "Organoids Market - Forecasts from 2021 to 2026" report has been added to's offering.

Organoids refer to the artificially grown three dimensional cultures of tissues obtained from stem cells. The organoids demonstrate similar organ functionalities to those present in various organs and have the ability to self-renew and self-organize themselves. The rise in the organoid-led medical research and various discoveries made by them which are beneficial for the treatment of various diseases are contributing significantly to the market growth and is expected to bolster the market growth during the forecast period. Also, as the prevalence of cancer around the world is increasing, the organoids are increasingly being used to understand cancer cells better and consequently find better treatments for cancer, which in turn, is anticipated to surge the organoids market growth in the coming years. Better drug testing, personalized medicine and aspiration for creating transplantable organs in labs are also some of the factors which are expected to propel the organoids market growth during the forecast period.

The recent outbreak of the novel coronavirus disease is anticipated to positively impact the market growth to some extent. The organoids are increasingly being used during the Covid-19 pandemic to better understand the biology of the novel coronavirus and its effect on the human organs. The scientists developed mini lung organoids study how alveolar cells respond to SARS-CoV-2 infection. These utilities of organoids in understanding the virus led to growth in the organoids market and due to successful studies, the organoids is further anticipated to propel the market growth during the forecast period.

The organoids market has been classified on the basis of organ, application, end user, and geography. By Organ, the market has been classified on the basis of Liver, Brain, Lungs, Kidney, Intestine, Pancreas, and others. On the basis of Application, the segmentation has been done into Cancer research, Drug testing, Personalized medicine, Regenerative medicine, Therapeutic tools, and others. By End User, the market has been categorized into Biotechnology and Pharmaceutical Companies, Academic and Research Institutions, and Hospitals and Diagnostic Centers. Geographically, the market for Organoids has been distributed into North America, South America, Europe, Middle East and Africa, and Asia Pacific.

Companies Mentioned

  • STEMCELL Technologies, Inc.
  • Cellesce Ltd.
  • Hubrecht Organoid Technology
  • Definigen
  • 3Dnamics, Inc.
  • Organoid Therapeutics
  • PeproTech, Inc.
  • Thermo Fisher Scientific
  • Corning Incorporated (Life Sciences)
  • Merck KGgA

Key Topics Covered:

1. Introduction

1.1. Market Definition

1.2. Market Segmentation

2. Research Methodology

2.1. Research Data

2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of End-Users

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. Organoids Market Analysis, by Organ

5.1. Introduction

5.2. Liver

5.3. Brain

5.4. Lungs

5.5. Kidney

5.6. Intestine

5.7. Pancreas

5.8. Others

6. Organoids Market Analysis, by Application

6.1. Introduction

6.2. Cancer research

6.3. Drug testing

6.4. Personalized medicine

6.5. Regenerative medicine

6.6. Therapeutic tools

6.7. Others

7. Organoids Market Analysis, by End User

7.1. Introduction

7.2. Biotechnology and Pharmaceutical Companies

7.3. Academic and Research Institutions

7.4. Hospitals and Diagnostic Centers

8. Organoids Market Analysis, by Geography

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.3. South America

8.4. Europe

8.4.1. Germany

8.4.2. UK

8.4.3. Others

8.5. Middle East and Africa

8.6. Asia Pacific

8.6.1. China

8.6.2. Japan

8.6.3. South Korea

8.6.4. Others

9. Competitive Environment and Analysis

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. Company Profiles

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 09-Jun-2021